Citigroup
HALO icon

Citigroup’s Halozyme HALO Stock Holding History

Citigroup’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35M Buy
30,000
+6,300
+27% +$430K ﹤0.01% 2812
2026
Q1 		$1.53M Buy
+23,700
New +$1.67M ﹤0.01% 2841
2021
Q2 		– Sell
-85,600
Closed -$3.57M – 6238
2021
Q1 		$3.57M Buy
85,600
+84,100
+5,607% +$3.84M ﹤0.01% 2066
2020
Q4 		$64K Sell
1,500
-20,600
-93% -$740K ﹤0.01% 5871
2020
Q3 		$581K Sell
22,100
-500
-2% -$13.9K ﹤0.01% 3726
2020
Q2 		$606K Sell
22,600
-5,800
-20% -$131K ﹤0.01% 4063
2020
Q1 		$511K Sell
28,400
-18,900
-40% -$359K ﹤0.01% 3855
2019
Q4 		$839K Sell
47,300
-6,600
-12% -$114K ﹤0.01% 3940
2019
Q3 		$836K Buy
53,900
+38,400
+248% +$632K ﹤0.01% 3845
2019
Q2 		$266K Sell
15,500
-13,900
-47% -$224K ﹤0.01% 5015
2019
Q1 		$473K Sell
29,400
-7,100
-19% -$115K ﹤0.01% 4242
2018
Q4 		$534K Buy
36,500
+5,900
+19% +$94.1K ﹤0.01% 4064
2018
Q3 		$556K Buy
30,600
+7,300
+31% +$128K ﹤0.01% 4150
2018
Q2 		$393K Buy
23,300
+2,400
+11% +$45.4K ﹤0.01% 4359
2018
Q1 		$409K Sell
20,900
-29,600
-59% -$573K ﹤0.01% 4203
2017
Q4 		$1.02M Buy
50,500
+20,100
+66% +$370K ﹤0.01% 3322
2017
Q3 		$528K Buy
30,400
+9,700
+47% +$131K ﹤0.01% 4065
2017
Q2 		$265K Buy
20,700
+5,900
+40% +$78.8K ﹤0.01% 4554
2017
Q1 		$192K Buy
14,800
+3,900
+36% +$49.3K ﹤0.01% 4687
2016
Q4 		$108K Buy
10,900
+600
+6% +$6.57K ﹤0.01% 5726
2016
Q3 		$124K Sell
10,300
-2,700
-21% -$27.6K ﹤0.01% 5048
2016
Q2 		$112K Sell
13,000
-1,900
-13% -$18.7K ﹤0.01% 4982
2016
Q1 		$141K Buy
14,900
+7,700
+107% +$72.5K ﹤0.01% 5409
2015
Q4 		$125K Sell
7,200
-22,100
-75% -$352K ﹤0.01% 5170
2015
Q3 		$393K Buy
29,300
+19,800
+208% +$398K ﹤0.01% 3974
2015
Q2 		$215K Buy
+9,500
New +$167K ﹤0.01% 4383

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Citigroup's HALO Position: Q2 2026 in Review

Citigroup increased its Halozyme (HALO) stake by 177% in Q2 2026, buying an estimated $14.6M and bringing the position to 333,777 shares worth $26.1M. The position accounts for 0.01% of the portfolio, ranked #1022.

Citigroup first reported a position in HALO in Q2 2013 and has held it in 53 quarters since. The position peaked at $40.3M in Q3 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Citigroup held 333,777 shares of Halozyme worth $26.1M as of Q2 2026.
  • Citigroup bought 213,436 Halozyme shares in Q2 2026, an estimated $14.6M.
  • Halozyme made up 0.01% of Citigroup's portfolio in Q2 2026, its #1022 holding.
  • Citigroup first reported a position in Halozyme in Q2 2013 and has held it in 53 quarters since.
  • Citigroup's Halozyme position peaked at $40.3M in Q3 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.